ATRA Atara Bio Operating Profitability

Public company logo of Atara Bio (ATRA)

Atara Biotherapeutics (ATRA) is developing a high-yield asset in multiple sclerosis therapy, as evidenced by the operating margin curve, where the current value is -358.40. Business stability is supported by its own T-cell product manufacturing plant. Meanwhile, risks are mitigated through clinical cycles and strategic alliances with pharma behemoths, which shield late-stage tests from external shocks.

ATRA: Atara Biotherapeutics Operating Margin 07/04/2022 - 11/19/2026

Comprehensive metric breakdowns and analytics for Atara Biotherapeutics, Inc. (ATRA)

- share price and consensus valuation forecast:
Initial company analysis:ATRA, Atara Biotherapeutics
Finished products of Atara Bio

Operating margin reflects cost management efficiency, showing the share of profit from core operations before accounting for financial expenses and taxes. By analyzing the operating margin, an investor assesses the resilience of the Atara Biotherapeutics (ATRA) business model, where a strategic alliance with a European distribution partner helps mitigate the high risks associated with developing new T-cell therapies and stabilize operating cash flow.

Competitors of Atara Biotherapeutics

ARGX (argenx N.V.) - Operating Margin|Operating Return on Sales BioNTech Pharma BNTX|Operating Sales Margin ABVX (ABIVAX)|Operating Margin ADMA Biologics, Inc. (ADMA)|Operating Margin PTGX (protagonist-inc.com)|IMVT: Return on Sales by Operating Profit|KNSA - Operating Profitability|GRFS: Operating Profitability|ADPT (Adaptive Biotechnologies) - Operating Sales Margin|Return on Sales by Operating Profit CLDX|Operating Sales Margin AUPH|BCRX (BioCryst Pharmaceuticals) - Operating Profit Ratio|Operating Profitability Vera Pharma (VERA)|DNTH (Dianthus Therapeutics) - Operating Profit Rate|Pharvaris N.V. - Operating Sales Margin|Operating Profit Rate ABCL|TRML: Operating Sales Margin|PGEN (Precigen) - Return on Sales by Operating Profit|pharming.com (PHAR) - Operating Profitability|Nektar Corp (NKTR) - Operating Margin|UPB (upstreambio.com) - Operating Margin|ZBIO: Operating Profit Rate|Operating Margin IMNM|Profitability of Operations Gossamer Bio Inc|Operating Margin KALV (KalVista Pharma)|SEPN (Septerna Pharma) - Operating Profit Margin|PVLA: Operating Sales Margin|Operating Profit Margin SVRA|RIGL: Operating Margin|Return on Sales by Operating Profit ANAB|ATXS (Astria Corp) - Operating Margin|Return on Sales by Operating Profit ENGN (enGene Bio)|Operating Margin RAPT|Profitability of Operations Aerovate Therapeutics|Operating Profitability Aclaris Therapeutics Inc. ACRS|Profitability of Operations Kyverna Therapeutics Inc. (KYTX)|TLSA - Operating Profitability|CABA: Operating Profitability|VTYX (Ventyx Biosciences, Inc.) - Operating Sales Margin|THTX - Profitability of Operations|AVTX (avalotx.com) - Operating Margin|Operating Return on Sales Eledon Pharmaceuticals Inc. ELDN|Operating Margin AGEN|CLYM (Climb Bio, Inc.) - Operating Profit Rate|Operating Profitability zurabio.com ZURA|ATYR - Operating Sales Margin|Adagene Inc - Operating Margin|ImageneBio (IMA) - Operating Sales Margin|Shattuck Therapeutics (STTK) - Operating Profitability|Operating Return on Sales Equillium Inc (EQ)|Operating Sales Margin CNTB|Return on Sales by Operating Profit IMUX (Immunic, Inc.)|Operating Margin IFRX|Operating Margin X4 Pharma (XFOR)|Operating Margin ACET (adicetbio.com)|Operating Margin Celularity Inc. CELU|INMB - Operating Profitability|Operating Profit Rate BRNS (Barinthus Biotherapeutics)|KZR (kezarlifesciences.com) - Operating Sales Margin|Operating Sales Margin SAB Biotherapeutics Inc.|Operating Sales Margin AKTX|Operating Sales Margin enlivex.com (ENLV)|Operating Profitability Q32 Bio Inc. (QTTB)|GeoVax Labs, Inc. (GOVX) - Operating Profitability Margin|Operating Margin EDSA (Edesa Biotech Corp)|Profitability of Operations iBio (IBIO)|CARM - Operating Profitability|XTL Biopharmaceuticals (XTLB) - Operating Sales Margin|BOLT: Operating Margin|Operating Sales Margin HCW Biologics Inc.|Operating Profitability Aptevo|Return on Sales by Operating Profit AIM (AIM ImmunoTech, Inc.)|Operating Margin ADTX|Profitability of Operations GRI Bio Corp|Operating Margin XRTX (XORTX Therapeutics Inc)|Vyome Holdings (HIND) - Operating Return on Sales|Revelation Biosciences Corp - Operating Margin|INDP (Indaptus Therapeutics, Inc.) - Return on Sales by Operating Profit|SCNI: Operating Margin|CALI - Profitability of Operations|AFMD (Affimed N.V.) - Operating Margin|Operating Profitability ALLK|Operating Sales Margin HOOK (HOOKIPA Pharma, Inc.)|IGMS - Operating Return on Sales|Operating Profitability iTeos ITOS|Ocean Bio - Operating Profitability|TC BioPharm Ltd - Operating Margin|Operating Return on Sales thirdharmonicbio.com